ArticleInternational journal of molecular sciences2019

Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis.

Yue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.